Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

Bhattacharjee, A., Richards, W. G., Staunton, J. E., Li, C., Monti, S., Vasa, P. P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,558

Neuroblastoma: biological insights into a clinical enigma

Brodeur, G. M. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1014 · Cited by 2,161

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasPreprint

Jackson, E. L., Willis, N. A., Mercer, K. L., Bronson, R. T., Crowley, D. G., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,927

Effects of an Rb mutation in the mouse

Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755

The RB and p53 pathways in cancer

Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690

Simplified mammalian DNA isolation procedure

Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. J. M. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4293 · Cited by 1,497

Diversity of gene expression in adenocarcinoma of the lung

Garber, M. E., Troyanskaya, O. G., Schlüns, K., Petersen, S., Thäsler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G., Perou, C. M., Whyte, R. I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241500798 · Cited by 1,301

Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer

Watkins, D. N., Berman, D. M., Burkholder, S. G., Wang, B., Beachy, P. A., & Baylin, S. B. (2003) · Nature · doi:10.1038/nature01493 · Cited by 1,082

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer

Jonkers, J., Meuwissen, R. L. J., van der Gulden, H. M. L., Peterse, H. L., van der Valk, M., & Berns, A. J. M. (2001) · Nature Genetics · doi:10.1038/ng747 · Cited by 1,044

Induction of medulloblastomas in p53 -null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum

Marino, S., Vooijs, M., van der Gulden, H., Jonkers, J., & Berns, A. (2000) · Genes & Development · doi:10.1101/gad.14.8.994 · Cited by 920

24-Methyl-Cholesta-5,24(28)-Diene-3β,19-diol-7β-Monoacetate Inhibits Human Small Cell Lung Cancer Growth In Vitro and In Vivo via Apoptosis Induction

Chung, T.-W., Su, J., Lin, C., Li, Y., Chao, Y., Lin, S., & Chan, H. (2017) · Marine Drugs · doi:10.3390/md15070210 · Cited by 13

Of mice without pockets: mouse models to study the function of Rb family proteins

Vidal, A. (2007) · Frontiers in bioscience · doi:10.2741/2403 · Cited by 13

The Tumor Pathology of Genetically Engineered MiceA New Approach to Molecular Pathology

DCARDIFF, R., JMUNN, R., & JGALVEZ, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012369454-6/50052-2 · Cited by 13

Stimulation of cGAS-STING pathway as a challenge in the treatment of small cell lung cancer: a feasible strategy?

Miglietta, G., Russo, M. V., Capranico, G., & Marinello, J. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02821-5 · Cited by 12

Fragmentation of Small-Cell Lung Cancer Regulatory States in Heterotypic Microenvironments

Schaff, D. L., Singh, S., Kim, K., Sutcliffe, M. D., Park, K.-S., & Janes, K. A. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1036 · Cited by 12

The emerging role of the gut microbiome in cancer cell plasticity and therapeutic resistance

Mondal, P., & Meeran, S. M. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10138-7 · Cited by 12

Lung Cancer Chemoprevention

Keith, R. L. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201107-038ms · Cited by 12

Implementing amplicon-based next generation sequencing in the diagnosis of small cell lung carcinoma metastases

Meder, L., König, K., Fassunke, J., Ozretić, L., Wolf, J., Merkelbach‐Bruse, S., Heukamp, L. C., & Buettner, R. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.11.002 · Cited by 12

Clinical Significance of p16 INK4a and p53 Overexpression in Endocrine Tumors of the Gastrointestinal Tract

Li, A. F., Tsay, S., Liang, W.-Y., Li, W.-Y., & Chen, J.-Y. (2006) · American Journal of Clinical Pathology · doi:10.1309/5x6w-byj3-u94e-eknn · Cited by 12

Methods to Study Metastasis in Genetically Modified MicePreprint

Kabeer, F., Beverly, L. J., Darrasse-Jèze, G., & Podsypanina, K. (2016) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top069948 · Cited by 12

Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase

Merle, N., Elmshäuser, S., Straßheimer, F., Wanzel, M., König, A. M., Funk, J. S., Neumann, M., Kochhan, K., Helmprobst, F., Pagenstecher, A., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01661-2 · Cited by 11

Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer

Liu, Y., Wu, Q., Jiang, B., Hou, T., Wu, C., Wu, M., & Song, H. (2024) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0405 · Cited by 11

Molecular cloning, expression pattern analysis of porcine Rb1 gene and its regulatory roles during primary dedifferentiated fat cells adipogenic differentiation

Hu, X., Luo, P., Peng, X., Song, T., Zhou, Y., Wei, H., Peng, J., & Jiang, S. (2015) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.01.016 · Cited by 11

Results from a biomarker study to accompany a phase II trial of RRx-001 with reintroduced platinum-based chemotherapy in relapsed small cell carcinoma

Lee, M.-J., Tomita, Y., Yuno, A., Lee, S., Abrouk, N., Oronsky, B. T., Caroen, S. Z., & Trepel, J. B. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1863947 · Cited by 11

Lung stem cells in regeneration and tumorigenesis

Chen, Y., Xue, Y., Jin, Y., & Ji, H. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2020.12.004 · Cited by 11

Ectopic expression of a small cell lung cancer transcription factor, INSM1 impairs alveologenesis in lung development

Chen, C., Breslin, M. B., & Lan, M. S. (2016) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0215-3 · Cited by 11

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Lim, M., Fletcher, N. L., Reed, A. E. M., Flint, M., Thurecht, K. J., Saunus, J. M., & Lakhani, S. R. (2022) · Journal of Visualized Experiments · doi:10.3791/64216 · Cited by 11

Modeling the developmental origins of pediatric cancer to improve patient outcomes

Amatruda, J. F. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048930 · Cited by 11

Genetic Alteration and Their Significance on Clinical Events in Small Cell Lung Cancer

Jiao, S., Zhang, X., Wang, D., Fu, H., & Xia, Q. (2022) · Cancer Management and Research · doi:10.2147/cmar.s356037 · Cited by 10

A translational approach to lung cancer research: From EGFRs to Wnt and cancer stem cells.

Yagui‐Beltrán, A., & Jablons, D. M. (2009) · PubMed · Cited by 10

Exploring natural killer cell immunology as a therapeutic strategy in lung cancer

Hess, J. B., Sutherland, K. D., & Best, S. A. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-765 · Cited by 10

RB1, Cancer Lineage Plasticity, and Therapeutic Resistance

Zhang, L., & Goodrich, D. W. (2022) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070120-092840 · Cited by 10

AKT phosphorylation as a predictive biomarker for PI3K/mTOR dual inhibition-induced proteolytic cleavage of mTOR companion proteins in small cell lung cancer

Hung, M., Wang, W.-P., & Chi, Y. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00862-y · Cited by 10

Physiological and Pathological Functions of Mammalian MicroRNAs

Liu, M., Jiang, S., Lu, Z., Li, Y., & Young, K. H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00223-2 · Cited by 10

Comparative proteomics of small cell lung carcinoma

Ziv, T., Barnea, E., Segal, H., Sharon, R., Beer, I., & Admon, A. (2006) · Cancer Biomarkers · doi:10.3233/cbm-2006-2601 · Cited by 10

Cellular Origins and Lineage Plasticity in CancerPreprint

Pitarresi, J. R., & Stanger, B. Z. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041389 · Cited by 10

p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism

Acosta, J., Li, Q., Freeburg, N. F., Murali, N., Indeglia, A., Grothusen, G. P., Cicchini, M., Mai, H., Gladstein, A. C., Adler, K. M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40161-9 · Cited by 9

Neuroendocrine Transformation as a Mechanism of Resistance to Targeted Lung Cancer Therapies: Emerging Mechanisms and Their Therapeutic Implications

Joshi, A., Bhaskar, N., & Pearson, J. D. (2025) · Cancers · doi:10.3390/cancers17020260 · Cited by 9

Lack of caspase 8 directs neuronal progenitor-like reprogramming and small cell lung cancer progression

Androulidaki, A., Liu, F., Bebber, C. M., Kisis, I., Sakthivelu, V., Hunold, P., Koerner, L., Dahlhaus, A., Yapici, F. I., Grimm, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67142-4 · Cited by 10

A blood-brain barrier-like vascular gate limits immunotherapy efficacy in neuroendocrine cancers

Wang, Y., Zhong, A., Wang, B., Zhai, X., Lei, C., Liang, Z., Deng, X., Zhong, J., Xiao, C., Zheng, J., et al. (2026) · Cell · doi:10.1016/j.cell.2026.04.017 · Cited by 10

NTRK-fusions in pediatric thyroid tumors: Current state and future perspectives

Casado‐Medrano, V., O’Neill, A., Halada, S., Laetsch, T. W., Bauer, A. J., & Franco, A. T. (2022) · Cancer Genetics · doi:10.1016/j.cancergen.2022.02.009 · Cited by 9

Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy

Biswas, S., Kang, K., Ng, K. P., Radivoyevitch, T., Schalper, K. A., Zhang, H., Lindner, D. J., Thomas, A., MacPherson, D. P., Gastman, B., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113016 · Cited by 9

The CDKN1B-RB1-E2F1 pathway protects mouse spermatogonial stem cells from genomic damage

Tanaka, T. S. T., Kanatsu‐Shinohara, M., & Shinohara, T. (2015) · Journal of Reproduction and Development · doi:10.1262/jrd.2015-027 · Cited by 9

Notch signaling and Tp53/RB1 pathway in pulmonary neuroendocrine tumorigenesis

Ito, T., Matsuo, A., & Hassan, W. A. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.03.11 · Cited by 9

A Multipronged Approach Establishes Covalent Modification of β-Tubulin as the Mode of Action of Benzamide Anti-cancer Toxins

Povedano, J. M., Rallabandi, R., Bai, X. L., Ye, X., Liou, J., Chen, H., Kim, J., Xie, Y., Posner, B. A., Rice, L. M., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01482 · Cited by 9

Development of a Conditional Mouse Model for Head and Neck Squamous Cell Carcinoma

Bindels, E. M., & van den Brekel, M. W. M. (2004) · KARGER eBooks · doi:10.1159/000082457 · Cited by 9

The Genomic Revolution and Endocrine Pathology

Couto, S. S., & Cardiff, R. D. (2008) · Endocrine Pathology · doi:10.1007/s12022-008-9042-2 · Cited by 9

Challenges and Opportunities of Nanomedicine: Novel Comprehensive Approaches for Brain Metastasis

Xiang, Y., Li, Z., Pan, D., Gong, Q., Luo, K., & Liu, Y. (2023) · Small Structures · doi:10.1002/sstr.202300148 · Cited by 8

Novel insights into RB1 in prostate cancer lineage plasticity and drug resistance

Ma, M., Zhu, Y., Xiao, C., Li, R., Cao, X., Kang, R., Wang, X., & Li, E. (2024) · Tumori Journal · doi:10.1177/03008916231225576 · Cited by 10

Orbi‐SIMS Mediated Metabolomics Analysis of Pathogenic Tissue up to Cellular Resolution

Kern, C., Scherer, A., Gambs, L., Yuneva, M. O., Walczak, H., Liccardi, G., Saggau, J., Kreuzaler, P. A., & Rohnke, M. (2024) · Chemistry - Methods · doi:10.1002/cmtd.202400008 · Cited by 8

NF-κB potentiates tumor growth by suppressing a novel target LPTS

Liu, D., Miao, H., Zhao, Y., Kang, X., Shang, S., Xiang, W., Shi, R., Hou, A., Wang, R., Zhao, K., et al. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0196-8 · Cited by 8

Pre-clinical models of small cell lung cancer and the validation of therapeutic targets

Sui, J. S. Y., Martin, P., & Gray, S. G. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1732353 · Cited by 8

Recent advances in lung cancer genomics: Application in targeted therapy

Pathak, N., Chitikela, S. D., & Malik, P. S. (2021) · Advances in genetics · doi:10.1016/bs.adgen.2021.08.004 · Cited by 9

Preinvasive Disease

Kerr, K. M., & Fraire, A. E. (2008) · Springer eBooks · doi:10.1007/978-0-387-72114-9_3 · Cited by 8

Lung premalignancy induced by mutant B-Raf, what is thy fate? To senesce or not to senesce, that is the question: Figure 1.Preprint

Haigis, K. M., Wistuba, I. I., & Kurie, J. M. (2007) · Genes & Development · doi:10.1101/gad.1532107 · Cited by 8

Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review

Kouroukli, O., Bravou, V., Giannitsas, K., & Tzelepi, V. (2024) · Cancers · doi:10.3390/cancers16040805 · Cited by 7

Nuclear factor I/B: Duality in action in cancer pathophysiology

Perumal, N., Gopalakrishnan, P., Burkovetskaya, M. E., Doss, D., Dukkipati, S. S., Kanchan, R. K., & Mahapatra, S. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217349 · Cited by 7

A mesenchymal-like subpopulation in non-neuroendocrine SCLC contributes to metastasis

Jin, Y., Xiao, T., Feng, Y., Yang, J., Guo, C., Hu, L., & Ji, H. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.05.007 · Cited by 7

Towards updated understanding of brain metastasis.

Wang, S., Feng, Y., Chen, L., Yu, J., Ongeval, C. V., Bormans, G. M., Li, Y., & Ni, Y. (2022) · PubMed Central · Cited by 7

Genetic tracing uncovers the importance of epithelial-to-mesenchymal transition in small cell lung cancer chemotherapy resistance but not metastasis

Chen, Y., Guo, C., Cai, X., Hu, L., Tong, X., Xue, Y., Zhao, Q., Zhang, T., Chen, Y., Fang, Y., et al. (2024) · Cell Discovery · doi:10.1038/s41421-024-00687-8 · Cited by 7

The retinoblastoma protein, RB, is required for gastrointestinal endocrine cells to exit the cell cycle, but not for hormone expression

Wang, Y., Ray, S. K., Hinds, P. W., & Leiter, A. B. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.08.052 · Cited by 8

Mutational Events in Lung Cancer

Morgensztern, D., Devarakonda, S. H. K., Mitsudomi, T., Maher, C. A., & Govindan, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52357-8.00011-1 · Cited by 8

Genetic Mouse Models of Cancer

Winslow, M. M., & Jacks, T. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00009-3 · Cited by 7

Genomic based analyses reveal unique mutational profiling and identify prognostic biomarker for overall survival in Chinese small-cell lung cancer

Wang, Y., Han, X., Wang, X., Sheng, W., Chen, Z., Shu, W., Han, J., Zhao, S., Dai, Y., Wang, K., et al. (2019) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyz131 · Cited by 7

Molecular Biology of Lung Preneoplasia

Kadara, H. N., & Wistuba, I. I. (2014) · Lung Cancer · doi:10.1002/9781118468791.ch6 · Cited by 7

Evaluation of CDK Inhibitor Selectivity

Bach, S., Blondel, M., & Meijer, L. (2006) · Enzyme inhibitors series/CRC enzyme inhibitors series · doi:10.1201/9781420005400.ch5 · Cited by 7

Molecular subtyping dictates therapeutic response to anti-PD-L1 immunotherapy in ES-SCLC

Zhang, Q., Wang, G., Yan, W., Wang, D., Yin, J., Song, Y., Ye, M., & Lv, T. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04068-2 · Cited by 6

Evaluating RB1 and p53 as diagnostic markers in treatment‐related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53

Ueki, H., Jimbo, N., Terakawa, T., Hara, T., Tobe, T., Hirata, J., Wakita, N., Okamura, Y., Suzuki, K., Bando, Y., et al. (2024) · The Prostate · doi:10.1002/pros.24791 · Cited by 6

A novel mouse model recapitulating the MMR-defective SCLC subtype uncovers an actionable sensitivity to immune checkpoint blockade

Ibruli, O., Rose, F., Beleggia, F., Schmitt, A., Cartolano, M., Fernández, L. T., Saggau, J., Bonasera, D., Kiljan, M., Gözüm, G., et al. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05942-9 · Cited by 6

Organotypic Brain Cultures for Metastasis Research

Zhu, L., & Valiente, M. (2020) · Neuromethods · doi:10.1007/978-1-0716-0856-2_6 · Cited by 6

Genetic and epigenetic features of neuroendocrine prostate cancer and their emerging applications

Zhang, X., Barnett, E., Smith, J., Wilkinson, E. J., Subramaniam, R. M., Zarrabi, A. D., Rodger, E. J., & Chatterjee, A. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2023.06.002 · Cited by 6

Towards a Disease Ontology

Schofield, P. N., Rozell, B., & Gkoutos, G. V. (2007) · Computational biology · doi:10.1007/978-1-84628-885-2_5 · Cited by 6

Neuroendocrine Lung Cancer Mouse Models: An Overview

Lorz, C., Oteo, M., & Santos, M. (2020) · Cancers · doi:10.3390/cancers13010014 · Cited by 6

Transgenic Mice in Biomedical Research

Voncken, J. W., & Hofker, M. H. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200400155 · Cited by 6

Intratumoral heterogeneity and potential treatment strategies in small cell lung cancer

Yang, Y., Liu, N., Wu, J., Wu, Q., Zhao, J., Shi, Y., Shen, M., Xu, Z., Shi, Y., Yu, J., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1657441 · Cited by 5

RB1 inactivation in cutaneous carcinomas

Liv, T., Touzé, A., Schrama, D., Guyétant, S., Samimi, M., Tetzlaff, M. T., Wood, B. A., Harms, P. W., & Kervarrec, T. (2025) · Histopathology · doi:10.1111/his.70056 · Cited by 5

Dual Function of Notch Signaling in Cancer: Oncogene and Tumor Suppressor

Koch, U., & Radtke, F. (2018) · Springer eBooks · doi:10.1007/978-1-4939-8859-4_3 · Cited by 5

Preclinical Models of Brain Metastases

Wu, A. M. L., Paranjape, A. N., & Gril, B. (2019) · Springer eBooks · doi:10.1007/978-3-030-23417-1_7 · Cited by 5

Candidate Biomarker of Response to Immunotherapy In Small Cell Lung Cancer

Shen, Y., Liu, Z., Chen, Y., Shi, X., Dong, S., & Wang, B. (2025) · Current Treatment Options in Oncology · doi:10.1007/s11864-025-01292-x · Cited by 5

Lineage transcription factors co-regulate subtype-specific genes providing a roadmap for systematic identification of small cell lung cancer vulnerabilitiesPreprint

Pozo, K., Kollipara, R. K., Kelenis, D. P., Rodarte, K. E., Zhang, X., Minna, J. D., & Johnson, J. E. B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.13.249029 · Cited by 5

Neuronal mimicry generates an ecosystem critical for brain metastatic growth of SCLCPreprint

Qu, F., Cao, S., Michno, W., Madubata, C. J., Puno, A., Drainas, A. P., Lee, M. C., Yang, D., Toland, A. M. S., Kong, C. S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.10.455426 · Cited by 5

Preclinical Modeling of Pathway-Targeted Therapy of Human Lung Cancer in the MousePreprint

Vaishnavi, A., Kinsey, C. G., & McMahon, M. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041385 · Cited by 5

Baseline retinoblastoma transcriptional corepressor 1 (Rb1) functional inactivation is a pre-requisite but not sufficient for small-cell histological transformation in epidermal growth factor receptor (EGFR) mutant lung adenocarcinomas post-tyrosine kinase inhibitor therapy

Nambirajan, A., Rathor, A., Baskarane, H., Anju, G. S., Khurana, S., Sushmitha, S., Sharma, A., Malik, P. S., & Jain, D. (2025) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-025-04054-0 · Cited by 4

Neuroendocrine cells in lung development and disease

Dash, B., Kim, E., & Sun, X. (2021) · European Respiratory Society eBooks · doi:10.1183/2312508x.10025020 · Cited by 4

Metastatic Organotropism in Small Cell Lung Cancer

Krishnamurthy, M., Dhall, A., Sahoo, S., Schultz, C. W., Baird, M. A., Desai, P., Odell, J., Takahashi, N., Nirula, M., Zhuang, S., et al. (2025) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2025.07.027 · Cited by 4

Genomic alterations in small cell lung cancer and their clinical relevance

Wildey, G. M., & Dowlati, A. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.07.05 · Cited by 4

Carcinogenic Responses of the Respiratory Tract

Hahn, F. F., & Hutt, J. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00909-x · Cited by 5

Neuroendocrine cells

Cheng, C.-Y., & Nikitin, A. Y. (2011) · Cell Cycle · doi:10.4161/cc.10.21.18034 · Cited by 4

Stem cells and cancer in the aerodigestive tract

Alison, M. R. (2009) · European Journal of Cancer · doi:10.1016/s0959-8049(09)70031-0 · Cited by 4

Strategies to Target Chemoradiotherapy Resistance in Small Cell Lung Cancer

Yu, T., & Lok, B. H. (2024) · Cancers · doi:10.3390/cancers16203438 · Cited by 4

Myc family proteins: Molecular drivers of tumorigenesis and resistance in neuroendocrine tumors

Hylton-McComas, H. M., Cordes, A. F., Floros, K. V., Faber, A. C., Drapkin, B. J., & Miles, W. O. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189332 · Cited by 3

Performance of Immunohistochemistry to Detect Rb/p53 Alterations in High-Grade Neuroendocrine Neoplasms: Staining Patterns and Comparison with Genetic Testing

Chen, R., Tihy, M., Lacroix, L., Rycke, O. D., Lacombe, C., Just, P. A., Cazes, A., Svrcek, M., de Montpréville, V., Antoine, M., et al. (2025) · Endocrine Pathology · doi:10.1007/s12022-025-09885-w · Cited by 3

Autophagic flux modulates tumor heterogeneity and lineage plasticity in SCLC

Hao, Y., Li, M., Liu, W., Ma, Z., & Liu, Z. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2024.1509183 · Cited by 3

Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer

Zhang, G.-J., Pannucci, A., Ivanov, A. A., Switchenko, J. M., Sun, S.-Y., Sica, G. L., Liu, Z.-T., Huang, Y., Schmitz, J. C., & Owonikoko, T. (2025) · Cancers · doi:10.3390/cancers17030446 · Cited by 1

A Review on Small-Cell Lung Cancer: Epidemiology, Pathophysiology, Risk Factors, Diagnosis, Clinical Management and Treatment Modalities

Alam, M. S. (2023) · International Journal of Current Science Research and Review · doi:10.47191/ijcsrr/v6-i1-16 · Cited by 3

Tumor grade-associated genomic mutations in Chinese patients with non-small cell lung cancer

Wang, Y., Qin, S., Liang, Y., Yan, L., Zheng, M., Zeng, Y., & Lu, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1119575 · Cited by 3

Experimental Animal Models for Studying Lung Cancer

Liu, J., & Johnston, M. R. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0772-1_12 · Cited by 3

Genetically engineered mouse models for lung cancer

Li, H., Kwak, I., & DeMayo, F. J. (2005) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2005.05.020 · Cited by 3

Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies

Jalal, S. I., Hanna, N. H., Zon, R. T., Masters, G. A., Borghaei, H., Koneru, K., Badve, S., Prasad, N. K., Somaiah, N., Wu, J., et al. (2014) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000160 · Cited by 3

The Respiratory Tract

Braun, A. C., Ernst, H., Schaudien, D., Hoymann, H.-G., & Rittinghausen, S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382008-2.00012-x · Cited by 3

The development and characterization of patient derived xenografts from non-small cell lung cancer brain metastases

Baschnagel, A. M., Kaushik, S., Durmaz, A., Goldstein, S., Ong, I. M., Abel, L., Clark, P. A., Leal, T., Buehler, D. G., Iyer, G., et al. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.01.061 · Cited by 3

Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation

Song, Y., Wang, Y., Guan, A., Xue, J., Li, B., Huang, Z., Zheng, Z., Liang, N., Yang, Y., & Li, S. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1132940 · Cited by 3

Roles of p53 and pRB Tumor Suppressor Networks in Human Cancer: Insight from Studies in the Engineered Mouse

Sage, J., Attardi, L. D., & Dyke, T. V. (2011) · Springer eBooks · doi:10.1007/978-0-387-69805-2_14 · Cited by 3

Advances in Preclinical Models of Small Cell Lung Cancer

Zhao, G., Zhao, Z., & Jia, Y. (2019) · Med One · doi:10.20900/mo.20190019 · Cited by 3

Cancer Stem Cells: Similarities and Variations in the Theme of Normal Stem Cells

Bapat, S. A., Collins, A. T., Dean, M. C., Nephew, K. P., & Rasheed, S. (2008) · doi:10.1002/9780470391594.ch1 · Cited by 3

Reversible therapeutic resistance in EGFR mutant lung cancer caused by RB1 loss induced lineage plasticityPreprint

Zhang, L., Chinnam, M., Balk, B., Zhang, X., Wang, Y., Shaurova, T., Alam, S., Pokharel, S., Singh, P., Jacobi, J. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.04.668485 · Cited by 3

Mouse models for cancer research – current state and the perspective

Gercakova, K., Poturnajova, M., Tyčiaková, S., Režuchová, I., & Matúšková, M. (2024) · Neoplasma · doi:10.4149/neo_2024_240328n140 · Cited by 3

An Autochthonous Model of Lung Cancer Identifies Requirements for Cellular Transformation in the Naked Mole Rat

Shepard, A., Troutman, S. A., Hoxha, S., Lester, D., Khaled, W. T., Smith, E. S. J., Park, T. J., Buffenstein, R., Du, D., Teng, M., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-0526 · Cited by 2

LSD1 inhibitor, TAS1440, disrupts INSM1-LSD1 complex activating tumor-suppressive pathways via transcriptional reprogramming in neuroendocrine SCLC

Machida, T., Gong, Y., Tsukioka, S., Onodera, A., Nakayama, A., Hashimoto, N., Fuchigami, T., Nishimura, M., Ogino, T., Kurimoto, R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70984-1 · Cited by 2

Different strokes

Greenwood, E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1216 · Cited by 2

Abstract SY10-02: Mouse models for (non) small cell lung cancer: Heterogeneity and cell of origin

Berns, A. J. M., Sutherland, K., Kwon, M. C., Proost, N., & Calbó, J. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-sy10-02

Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung

Sutherland, K. D., Proost, N., Brouns, I., Adriaensen, D., Song, J.-Y., & Berns, A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.019 · Cited by 534

MS32.01 Genetic Mouse Models (GEMMS)

Mollaoglu, G., Chalishazar, M. D., Huang, F., Guthrie, M. R., Böhm, S., Br€Agelmann, J., Sen, T., Byers, L. A., Johnson, J. L., Wechsler‐Reya, R. J., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.08.208

Loss of p130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung Carcinoma

Schaffer, B. E., Park, K.-S., Yiu, G., Conklin, J. F., Lin, C., Burkhart, D. L., Karnezis, A. N., Sweet-Cordero, A., & Sage, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4228 · Cited by 248